NK-92 Cells with Cytokine Induced Memory-Like Cytotoxicity And Derivatives Thereof

ACTIVATION AND PROLIFERATION OF CYTOTOXIC LYMPHOCYTES

A METHOD OF PRODUCING INNATE LYMPHOID CELLS FOR USE IN THERAPY

COMPOSITIONS AND METHODS RELATED TO POTENT CYTOTOXIC M-CENK CELLS FROM CD3/CD14-DEPLETED APHERESIS PRODUCTS

ENGINEERED STEM CELLS AND USES THEREOF

RECOMBINANT PRODUCTION OF GROWTH FACTORS IN ALGAE FOR CELL CULTURE APPLICATIONS

COMPOSITIONS AND METHODS FOR NK CELL DIFFERENTIATION

SELECTION OF OPTIMAL CELL DONORS AND METHODS AND COMPOSITIONS FOR ENHANCED EXPANSION AND CYTOTOXICITY OF DONOR CELLS

CANCER-KILLING CELLS

CRYOPRESERVATION OF NK CELL PRODUCTS FOR OFF-THE-SHELF IMMUNOTHERAPY

CELLULAR MICROCOMPARTMENTS COMPRISING LYMPHOCYTES FORMING A 3D GROUPED CULTURE AND HAVING A LOW GRANZYME B CONTENT

METHOD OF USING FACTOR RICH PRODUCT FROM UMBILICAL CORD MESENCHYMAL STEM CELLS TO INCREASE COLLAGEN AND ELASTIN IN HUMAN SKIN

METHODS FOR ACTIVATION AND EXPANSION OF ENGINEERED NATURAL KILLER CELLS AND COMBINATIONS WITH ANTIBODIES

CELLULAR MICROCOMPARTMENTS COMPRISING LYMPHOCYTES FORMING A GROUPED 3D CULTURE AND HAVING A LOW TNF ALPHA CONTENT

COMPOSITIONS AND METHODS FOR IMMUNE CELL MODULATION IN ADOPTIVE IMMUNOTHERAPIES

NOVEL DUAL CULTURE METHOD FOR CULTURING IMMUNE CELLS AND NATURAL KILLER CELLS, AND USE THEREOF

METHODS AND COMPOSITIONS HIGH SCALE THERAPEUTIC PRODUCTION OF MEMORY NK CELLS

METHOD FOR PRODUCING MEMORY-LIKE NATURAL KILLER CELLS AND ANTICANCER USE OF MEMORY-LIKE NATURAL KILLER CELLS PRODUCED THEREBY

METHOD FOR EXPANSION CULTURE OF GAMMA-DELTA T CELL

METHOD OF PRODUCING NATURAL KILLER CELLS AND COMPOSITION FOR TREATING CANCER

GENE EDITING METHODS FOR MODULATING EXPRESSION OF ID-3, AN INHIBITOR OF DNA-BINDING TRANSCRIPTION FACTORS, THEREBY AFFECTING T-CELL FUNCTION

COMPOSITIONS AND METHODS FOR EXPANDING EX VIVO NATURAL KILLER CELLS AND THERAPEUTIC USES THEREOF

METHODS FOR EXPANDING T CELLS FOR THE TREATMENT OF CANCER AND RELATED MALIGNANCIES

IMMUNE CELL POPULATIONS AND USES THEREOF

METHODS FOR IMPROVING THE EFFICACY AND EXPANSION OF CHIMERIC ANTIGEN RECEPTOR-EXPRESSING CELLS

ANTIBODY LOADED IMMUNE CELLS AND METHODS FOR USE IN CANCER TREATMENT

EXPANSION OF MEMORY NATURAL KILLER CELLS

TUMOR INFILTRATION LYMPHOCYTE CULTURE MEDIUM AND APPLICATION THEREOF

ENGINEERED NATURAL KILLER (NK) CELLS AND RELATED METHODS

COMPOSITIONS AND METHODS FOR IMMUNOTHERAPY

METHOD FOR PRODUCING CD8alpha+beta+ CYTOTOXIC T CELLS

PHARMACEUTICAL COMPOSITION COMPRISING MODIFIED NATURAL KILLER CELLS AND ANTIGEN-SPECIFIC T CELLS, MANUFACTURING METHOD THEREOF, AND METHOD OF USING THE SAME

Highly Potent M-CENK Cells And Methods

IMMUNE CELL PROLIFERATION/ACTIVATION KIT AND IMMUNE CELL CULTURE METHOD USING SAME PROLIFERATION/ACTIVATION KIT

CANCER-KILLING CELLS

METHODS FOR ACTIVATION AND EXPANSION OF NATURAL KILLER CELLS AND COMBINATIONS WITH BISPECIFIC ANTIBODIES

Highly Potent M-CENK Cells And Methods

METHODS, COMPOSITIONS, AND KITS FOR EXPANDING NATURAL KILLER CELLS

CANCER-KILLING CELLS

PM21 PARTICLES TO IMPROVE BONE MARROW HOMING OF NK CELLS

METHODS FOR ENGINEERING NON-NEURONAL CELLS INTO NEURONS AND USING NEWLY ENGINEERED NEURONS TO TREAT NEURODEGENERATIVE DISEASES

ENHANCED EXPANSION AND CYTOTOXICITY OF ENGINEERED NATURAL KILLER CELLS AND USES THEREOF

EXPANSION OF GAMMA DELTA T CELLS, COMPOSITIONS, AND METHODS OF USE THEREOF

SEED CELL MEDIUM OF TUMOR-INFILTRATING LYMPHOCYTE AND APPLICATION THEREOF

GENETICALLY MANIPULATED CELL STRAIN FOR ACTIVATING AND AMPLIFYING NK CELLS AND USE THEREOF

GENETICALLY-MODIFIED CELL LINE FOR NK CELL ACTIVATION AND AMPLIFICATION, AND USE THEREOF

FEEDER FREE CELL CULTURE METHODS FOR EXPANDING NATURAL KILLER CELL PREPARATIONS

Method for inhibiting growth of cancer cells using anti-cancer composition with mesenchymal stem cells conditioned medium

Natural Killer Cells for Treatment of Coronavirus Infection

METHODS AND COMPOSITIONS FOR ENHANCED EXPANSION AND CYTOTOXICITY OF NATURAL KILLER CELLS

LARGE-SCALE COMBINED CAR TRANSDUCTION AND CRISPR GENE EDITING OF T CELLS

METHODS FOR EXPANDING T CELLS FOR THE TREATMENT OF CANCER AND RELATED MALIGNANCIES

PDL1 POSITIVE NK CELL CANCER TREATMENT

METHOD FOR PRODUCING CAR GENE-INTRODUCED NK CELLS AND USE THEREOF

ADDITIVE COMPOSITION FOR NK CELL CULTURE MEDIUM, CULTURE METHOD FOR NK CELL BY USING SAME ADDITIVE COMPOSITION, AND COSMETICS COMPOSITION OBTAINED THEREBY FOR IMPROVING SKIN PROBLEMS

COMPOSITION, CULTURE MEDIUM AND METHOD FOR INDUCING AND/OR AMPLIFYING TSCM IN VITRO

METHOD FOR PRODUCING IMMUNOCYTES, AND USE THEREOF

CRYOPRESERVATION AND CELL CULTURE MEDIA

IMMUNE CELL FUNCTION

METHODS FOR THE SIMULTANEOUS EXPANSION OF MULTIPLE IMMUNE CELL TYPES, RELATED COMPOSITIONS AND USES OF SAME IN CANCER IMMUNOTHERAPY

FACTOR RICH PRODUCTS FROM UMBILICAL CORD MESENCHYMAL STEM CELLS

METHOD FOR PREDICTING EFFECT OF IMMUNE CHECKPOINT INHIBITOR

Compositions and methods for immune cell modulation in adoptive immunotherapies

CIML NK cells and Methods Therefor

Kit containing medium for culturing natural killer cells and method of effectively culturing natural killer cells using the same

FACTOR RICH PRODUCT FROM UMBILICAL CORD MESENCHYMAL STEM CELLS

METHOD FOR PRODUCING CD3-POSITIVE CELL

METHOD FOR PRODUCING MEMORY-LIKE NK CELLS WITH ABILITY TO EXPRESS HIGHER LEVELS OF NCRS, CYTOTOXICITY, AND IFN-y THAN NK CELLS IN HUMAN PERIPHERAL BLOOD

Modified natural killer cells, pharmaceutical composition, manufacturing method thereof, and method of using the same

UMBILICAL CORD LINING STEM CELLS AND CONDITIONED MEDIA THEREOF

Cancer-killing cells

METHOD FOR PRODUCING NATURAL KILLER CELLS

Expansion of γδ T cells, compositions, and methods of use thereof

INTRACELLULAR NITRIC OXIDE AS A BIOMARKER FOR INCREASED SUSCEPTIBILITY SYSTEMIC INFLAMMATION

Method of producing natural killer cells and composition for treating cancer

CIML NK cells and Methods Therefor

CIML NK cells and Methods Therefor

MEDICINE FOR TISSUE REGENERATION, AND PREPARATION METHOD THEREFOR

Compositions for expanding natural killer cells

Method of producing natural killer cells and composition for treating cancer

PM21 particles to improve bone marrow homing of NK cells

METHOD FOR IN VITRO ACTIVATION OF IMMUNE CELLS

Systems and methods for immunomodulation of mucosal-associated invariant T cells

Method for producing CD8alpha+beta+ cytotoxic t cells

Method of producing natural killer cells and composition for treating cancer

METHODS AND COMPOSITIONS HIGH SCALE THERAPEUTIC PRODUCTION OF MEMORY NK CELLS

Cancer-killing cells

METHOD OF CULTURING IMMUNE CELLS, KIT FOR THEREOF, IMMUNE CELL CULTURED MEDIUM OBTAINED BY SAME METHOD, COSMETIC COMPOSITION AND PHARMACEUTICAL COMPOSITION COMPRISING THEREOF

Compositions and methods for immune cell modulation in adoptive immunotherapies

METHODS FOR ENGINEERING NON-NEURONAL CELLS INTO NEURONS AND USING NEWLY ENGINEERED NEURONS TO TREAT NEURODEGENERATIVE DISEASES

EX VIVO EXPANSION METHOD FOR CORD BLOOD NK CELL, AND KIT AND APPLICATION THEREOF

Method of culturing NK cells and kits containing medium additions

ANGIOGENESIS USING STIMULATED PLACENTAL STEM CELLS

Methods for improving the efficacy and expansion of chimeric antigen receptor-expressing cells

Methods for high scale therapeutic production of memory NK cells

METHODS FOR ENGINEERING NON-NEURONAL CELLS INTO NEURONS AND USING NEWLY ENGINEERED NEURONS TO TREAT NEURODEGENERATIVE DISEASES

Vγ9Vδ2 T cell proliferation agent, method for producing activated Vγ9Vδ2 T cells, and uses thereof